Please login to the form below
Lexicon
This page shows the latest Lexicon news and features for those working in and with pharma, biotech and healthcare.
Sanofi sheds jobs in R&D restructuring
The FDA also recently rejected its Lexicon partnered SGLT1/SGLT2 inhibitor Zynquista.
Latest news
-
J&J’s Invokana first SGLT2 to show kidney disease benefits
Meanwhile Sanofi and Lexicon's Zynquista and Eli Lilly and Boehringer Ingeheim's market leader Jardiance are also both in renal outcomes trials, with their respective results expected by 2022.
-
Success for AZ, setback for Sanofi in type 1 diabetes
Sanofi has been less fortunate with its US marketing application for Lexicon Pharma-partnered dual SGLT1/SGLT2 inhibitor Zynquista (sotagliflozin) alongside insulin in type 1 diabetes, however, as this was rejected ... Both AZ and Sanofi/Lexicon’s
-
CHMP backs Lynparza in breast cancer, Dupixent in asthma
There was also another positive opinion for Sanofi, this time for its Lexicon Pharma-partnered SGLT1/2 inhibitor Zynquista (sotagliflozin) as an oral add-on to insulin therapy to improve blood
-
FDA adcomm split on Sanofi’s type 1 diabetes drug
According to Lexicon, sotagliflozin is also being tested in type 2 diabetes with phase 3 results due this later year. ... Sanofi licensed rights to sotagliflozin from Lexicon in 2015 for $300m upfront and up to $1.4bn in development, regulatory and sales
-
FDA starts review of Sanofi’s oral type 1 diabetes drug
According to Lexicon, sotagliflozin is also being tested in type 2 diabetes with phase III results due in 2019. ... Lexicon exercised an option to co-promote the drug in the US for the treatment of type 1 diabetes last year.
More from news
Approximately 2 fully matching, plus 14 partially matching documents found.
Latest Intelligence
-
Breaking from tradition - social media at medical congresses
Taking the opportunity to listen will also give you a sense of the tone of the online conversation, and very practically, the language, lexicon and hashtags that HCPs are using to
-
What pharma marketers can learn from Disney
We need to make it easy for audiences to consume our content using language and lexicon they are familiar with, and provide information in short relevant bites that is actionable in
-
It’s not the end of the world, is it?
True and transparent value. The phrase ‘value-based healthcare’ entered the industry’s lexicon some years ago and there isn’t a pharmaceutical or medical technology company in existence that does
-
The first, my last, my everything
Because if the modern-day lexicon is anything to go by, the patient has become The First, the Last, the Everything for the global industry.
-
Communication is the key to unlocking the potential of immuno-oncology
Marje Isabelle, Founder and CEO, Fertile Matters. This means working with others to define a new lexicon for cancer care; helping healthcare professionals stay on top of the deluge of new
More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.
Latest appointments
-
Weekly comms appointments
In this newly created position, Pyati will develop a science-driven strategy, implement situational assessments and workshops and develop scientific platforms and lexicons.
-
Linda Law joins Advicenne as US VP, clinical development and med affairs
Law’s career has seen her serve in various positions for pharmaceutical companies including Procter &Gamble, Lexicon Pharmaceuticals and she has consulted on evaluation and development projects with Takeda, Confluence and
-
Onconova appoints Ajay Bansal as chief financial officer
Bansal (pictured) served as chief financial officer at Complete Genomics since May 2010, having previously held the role of chief financial officer and executive VP of business development at Lexicon Therapeutics. ... In addition to his prior roles at
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Mastering the precision medicine opportunity
While some might say that this change in lexicon is merely a progression in language, I would argue there are differences in the two approaches to identifying and treating patients.
-
Social Media and Health: the Cure or the Disease?
He is also changing the Facebook lexicon, swapping 'community' for 'connection' as the ultimate good. . .
-
The science of experience planning in pharma media
Experience planning is a popular phrase in today’s marketing lexicon. It focuses on how each interaction with a (potential) customer is an ‘experience’ and how to best plan this in
-
The Seven Cs Of Cross-Functional Brand Planning
Thinking about the plan, the process, how we go about it, the tools and lexicon. This is as much about language and definitions as it is about planning steps, stages, philosophy
-
Framing, provocation, and truth
It seems to be a word creeping steadily into the promotional lexicon of marketing research.
More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.
Featured jobs
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
-
Account Director – UK Office
-
Excellent salary and benefits
- Account Director, Healthcare Communications
-
Salary TBC
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
Subscribe to our email news alerts
- Finch Therapeutics bags $53m for microbiome therapies
- MSD taps Austria’s Themis to bolster vaccine pipeline
- Early ‘no’ for GW Pharma’s epilepsy drug, but NICE vows to collaborate
- GSK preps filings for BCMA-targeting multiple myeloma drug
- Behaviour change – is there something missing?
- NICE’s long-serving chief exec Sir Andrew Dillon to step down
PMHub
Create Health
A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...
Latest intelligence
- Empowered patients: shaking the foundations of healthcare
- Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
- A uniquely English genomic medicine service
- The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
- Blended Intelligence
- Data is the most valued commodity of the modern world. For P&P it's all about the application....
Quick links
Infographics
